Format

Send to

Choose Destination
Eur J Gastroenterol Hepatol. 2018 Jun;30(6):668-675. doi: 10.1097/MEG.0000000000001097.

Transjugular intrahepatic portosystemic shunt creation for cirrhotic portal hypertension is well tolerated among patients with portal vein thrombosis.

Author information

1
Departments of Surgery.
2
Division of Gastroenterology and Hepatology, Weil-Cornell Medical Center.
3
Yale School of Public Health, Yale Center for Analytical Sciences, New Haven, Connecticut.
4
Albany Hospital Medical Imaging, Albany.
5
Departments of Medicine.
6
Radiology, New York University School of Medicine.
7
Radiology, Yale School of Medicine.
8
Northwell Health, Manhasset.
9
Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.

Abstract

BACKGROUND:

Portal vein thrombosis (PVT) develops in cirrhotic patients because of stagnation of blood flow. Transjugular intrahepatic portosystemic shunt (TIPS) creates a low-resistance conduit that restores portal venous patency and blood flow.

AIM:

The effect of PVT on transplant-free survival in cirrhotic patients undergoing TIPS creation was evaluated.

PATIENTS AND METHODS:

A multicenter, retrospective cohort study of patients who underwent TIPS creation for cirrhotic portal hypertension was carried out. A Cox model with propensity score adjustment was developed to evaluate the effect of PVT on 90-day and 3-year transplant-free survival. A subgroup analysis examining mortality of those with superior and inferior PVT was also carried out.

RESULTS:

A total of 252 consecutive TIPS creations were assessed, including 65 in patients with PVT. Survival of patients with high Model for End-stage Liver Disease scores (≥18) and PVT was not statistically different compared with patients with low Model for End-stage Liver Disease scores (<18) and no PVT at 90 days (P=0.46) and 3 years (P=0.42). Those with superior PVT had improved 90-day and 3-year survival both compared with patients with a inferior PVT and those without a PVT (P<0.01, all cases).

CONCLUSION:

The presence of PVT does not impair the prognosis of patients following TIPS creation, particularly in patients with superior portal occlusion.

PMID:
29462027
DOI:
10.1097/MEG.0000000000001097
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center